Invasive Ductal Breast Carcinoma Recruiting Phase 3 Trials for Paclitaxel (DB01229)

Also known as: Invasive Ductal Breast Cancer / Carcinoma, Ductal, Breast / Infiltrating ductular carcinoma / Breast ductal cancer invasive / Breast ductal cancer infiltrating / Infiltrating ductal breast cancer

DBCOND0047004 (Invasive Ductal Breast Carcinoma)Recruiting3 IdentifierTitlePurposeDrugs
NCT02879513Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant ChemotherapyTreatment